🔓 Unlock the full profile of Rohit Reddy Penaka (Aurobindo Pharmaceuticals), including verified contact details, financial insights, and professional associations.
See Rohit Reddy Penaka Full Profile
From IPOs, Funding Rounds & M&A — See Who’s Behind Each Deal
Below are the ✅ Verified Contact Details to help you connect directly:
Email: roh*****@aur******.com
Mobile: 68736*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Rohit Reddy Penaka is associated with multiple companies within the pharmaceutical sector, including Qule Pharma Pvt Ltd and Aurobindo Pharma GmbH, indicating a significant role in the healthcare and pharmaceutical industries.
- In the realm of company governance, Rohit Reddy Penaka is a director of Aurobindo Realty and Infrastructure Private Limited, highlighting contributions to infrastructure alongside the pharmaceutical sector.
- The Limited Review Report on the financial results for the quarter and half-year ended September 30, 2021, indicates a level of involvement in oversight and financial analysis in their management role.
- Rohit Reddy Penaka is linked to notable connections within the Aurobindo group, particularly related to the ultimate beneficiaries of several firm structures, showcasing an influential position within the corporate hierarchy.
- Aurobindo Pharma, under which Rohit Reddy Penaka's roles fall, is recognized as one of India's leading pharmaceutical companies, portraying the significant impact on the healthcare landscape.
- Legal challenges surfaced as Rohit Reddy Penaka faced scrutiny from enforcement agencies, particularly during investigations into the Aurobindo group, reflecting the complexities and pressures associated with high-level corporate governance.
- The network of relations analyzed demonstrates Rohit Reddy Penaka's extensive connections in the industry, indicative of strategic partnerships and collaboration opportunities within the sector.
- Rohit Reddy Penaka's prominence in the Aurobindo group underscores a commitment to advancing the company's market position and navigating regulatory and operational challenges in the pharmaceutical space.
| CIN/LLP | Company Name | Designation | Appointment Date |
|---|---|---|---|
| AAD-8379 | Prr Enterprises Llp | Designated Partner | 27 Apr 2015 |
| AAT-7174 | Avyaan Realtors Llp | Designated Partner | 07 Sep 2020 |
| U24232TG2011PTC076791 | Sacha Chemphar Private Limited | Whole-time director | 30 Sep 2011 |
| U24232TG2014PLC092422 | Auryn Labs Limited | Director | 20 Jan 2014 |
| U29219TG1993PTC016451 | Pravesha Industries Private Limited | Director | 30 Aug 2017 |
| U29249TG2019PTC136310 | Renuka Precision Systems Private Limited | Director | 24 Oct 2019 |
| U40101KA2001PTC029130 | Pavana Ganga Power Private Limited | Director | 01 Jun 2013 |
| U45209TG2013PLC085417 | Mahira Infra & Realty Limited | Director | 18 Jan 2013 |
| U70102TG2010PTC070535 | Rosa Avenues India Private Limited | Director | 23 Sep 2010 |
| U70109TG2022PTC168959 | Alv Shamshabad Private Limited | Director | 07 Dec 2022 |
| U73100TG2021PTC147738 | Shreas Biologicals Private Limited | Director | 14 Jan 2021 |
| U74900TG2014PTC096933 | Penaka Pharma (India) Private Limited | Director | 11 Aug 2021 |
| U74900TG2015PTC099015 | Rpr Holdings Private Limited | Director | 29 Sep 2017 |
| U74999TG2014PTC096668 | Rpr Sons Advisors Private Limited | Director | 30 Sep 2021 |
| CIN/LLP | Company Name | Designation | Appointment Date | End Date |
|---|---|---|---|
| AAD-8797 | Sanhoc Engineering Llp | Director | 30 Aug 2011| 16 January 2014 |